Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Giverny Capital Asset Management 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Giverny Capital Asset Management)

Primary Source Intelligence • Q3 2024 Letter Analysis

Giverny Capital Asset Management Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Giverny Capital Asset Management. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+18.89%

Digest Analysis

Quick Take

"Manager trimmed winners Progressive and Berkshire while adding clinical research firm Medpace. Despite outperformance, warns current valuations unsustainable and expects lower future returns while maintaining focus on highest-quality owner-managed businesses."

Executive Summary

Giverny Capital delivered strong Q3 performance with 6.99% quarterly returns and nearly 40% trailing twelve-month gains, benefiting from exceptional US corporate fundamentals. Manager David Poppe highlights that US companies achieve remarkable 20% returns on equity and 16% profit margins, far exceeding historical norms and international peers. The portfolio maintains focus on highest-quality businesses with owner-managers, exemplified by trimming appreciated positions in Progressive and Berkshire Hathaway while establishing a new position in clinical research organization Medpace Holdings. Despite strong performance, Poppe warns that current US market valuations appear expensive and may not be sustainable, as corporate profit margins have doubled from historical levels while many Americans feel disconnected from this prosperity. The manager acknowledges risks to the current capitalist model but maintains conviction in owning quality businesses, expecting lower future returns while believing stocks will continue outperforming other asset classes over decades.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

72%

CautiousHigh

High Conviction (72%)

Manager demonstrates high conviction through concentrated portfolio with named positions and specific weightings. Provides detailed thesis for new Medpace position and clear rationale for trimming decisions. Top 10 holdings represent 62.1% of portfolio, showing concentrated approach with owner-manager focus.

Growth Outlook

25%

BearishBullish

Bearish (25%)

Manager acknowledges strong US market fundamentals and corporate performance but expresses caution about sustainability of current valuations and profit margins. Describes market as expensive for a reason but questions whether 20% ROE and 16% margins can continue indefinitely.

Risk Appetite

10%

DefensiveAggressive

Defensive (10%)

Portfolio positioning shows selective trimming of appreciated positions and careful position sizing. Manager trimmed Progressive from 9.5% to 8% weight and reduced Berkshire, indicating measured risk management rather than aggressive deployment.

Capital Deployment

43%

De-riskingDeploying

Net Neutral (43%)

Net activity shows trimming of existing positions (Progressive and Berkshire) with proceeds used to establish new 2.5% position in Medpace. Overall activity suggests slight de-risking through position size management rather than aggressive deployment.

Forward Guidance

38%

CautiousExpansionary

Neutral (38%)

Manager explicitly encourages clients to temper expectations on future returns and states returns won't resemble what investors have enjoyed recently. Emphasizes patience and selectivity rather than aggressive deployment.

Language Signal

0%

BearishBullish

Bearish (0%)

Language is balanced between acknowledging strong fundamentals and expressing caution about sustainability. Uses both positive terms like extraordinary environment and cautionary language about expensive valuations and unsustainable margins.

Perceived Risk

65%

Low RiskElevated

Elevated Risk (65%)

Manager identifies multiple specific risks including expensive US valuations, sustainability questions about corporate margins, and political/social tensions around inequality. Discusses potential end of current capitalist era and acknowledges unpopularity of current system.

Opportunity Density

45%

ScarceAbundant

Selective (45%)

Manager describes having better opportunities elsewhere when selling Floor & Décor, but overall tone suggests selectivity is required. Spent significant time researching Medpace before buying, indicating opportunities exist but require patience and analysis.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

Manager emphasizes long-term approach with focus on owner-managers and multi-decade stock outperformance. Discusses holding Berkshire especially for those with low-cost basis and mentions stocks delivering higher returns over many decades, indicating patient capital approach.